Supreme (SUP) H2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2026 earnings summary
10 Jul, 2026Executive summary
Achieved record revenue growth of 17% year-over-year, reaching £270.2m, with a CAGR of 20% in revenue and 17% in EBITDA since 2021.
Growth driven by organic expansion (notably vaping) and acquisitions, all funded from free cash flow with no debt.
Major acquisitions included SlimFast (£20.6m) and 1001 (£1.7m), both immediately earnings-enhancing.
Diversified product portfolio across vaping, wellness, drinks, electricals, and household, managing 30 brands.
Expanded international footprint, especially in Hong Kong and the Middle East, and signed new licenses with Carabao and Lamborghini.
Financial highlights
Revenue up 17% year-over-year, with £27.1m from acquisitions and £19.1m from organic vaping growth.
Gross profit margin declined from 32% to 29% due to product mix shift.
Adjusted EBITDA reached £40.6m, with operating cash flow of £32–32.4m and year-end net cash of £7.5m.
Spent £13m on acquisitions and £6m on CapEx, yet remained cash generative.
Adjusted profit after tax was £22.2m; adjusted EPS at 18.9p.
Outlook and guidance
Positive start to the new year, focusing on integrating acquisitions and preparing for Vaping Products Duty (VPD) in October.
Expect revenue to increase post-tax implementation, but margins to decrease; cash generation expected to remain strong.
SlimFast identified as a significant growth opportunity with ongoing investment.
Baseline CapEx expected to normalize at £2m per year after recent one-off investments.
Open to further M&A, with £40m in undrawn banking facilities available.
Latest events from Supreme
- Record Adjusted EBITDA of £40.5m, with strong M&A-driven growth and improved margins.SUP
H2 20258 Jul 2026 - FY26 revenue and EBITDA are set to surpass expectations, driven by strong vape and wellness growth.SUP
Trading update20 Apr 2026 - Record revenue and profit growth, strong cash generation, and positive FY25 outlook.SUP
H2 202425 Feb 2026 - Upgraded FY25 outlook as revenue and EBITDA rise, boosted by Clearly Drinks acquisition.SUP
H1 202512 Jan 2026 - Revenue up 17% to £132.6m, led by acquisitions and growth in Vaping and Drinks & Wellness.SUP
H1 20269 Dec 2025